MARK THOMPSON: Open Payments
NPI 1265441729 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,029 in 92 payments from 10 companies in 2025. Trend: 2023 $488 · 2024 $1,702 · 2025 $2,029
Food & beverage: $2,009Education: $20
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 40 | $777 |
| Gilead Sciences, Inc. | 29 | $696 |
| Merck Sharp & Dohme LLC | 5 | $138 |
| ABBVIE INC. | 6 | $119 |
| Otsuka America Pharmaceutical, Inc. | 4 | $97 |
| EMD Serono, Inc. | 2 | $60 |
| Hologic Sales and Service, LLC | 2 | $42 |
| Exact Sciences Corporation | 2 | $42 |
| Novo Nordisk Inc | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
Products named: DOVATO, RUKOBIA, CABENUVA, APRETUDE, PIFELTRO, Biktarvy, REXULTI, VRAYLAR.
Industry payments across MI — which companies pay providers there.
